about
Severe Vincristine-induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study.The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children.Detection of busulfan adducts on proteins.Pharmacogenetic aspects of drug metabolizing enzymes in busulfan based conditioning prior to allogenic hematopoietic stem cell transplantation in children.The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation.GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation.GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study.Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation.Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine.The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation.Influence of age, sex, and haplotypes of thiopurine methyltransferase (TPMT) gene on 6- mercaptopurine toxicity in children with acute lymphoblastic leukemiaPossible involvement of microRNAs (miR-135a∗) in heart failure associated with 25bp deletion in MYBPC3 (cardiac myosin binding protein C) geneA simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometryA novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry
P50
Q34501587-1E71C21B-8E20-4536-81EA-CC12971914F1Q34973409-AF9ACC4C-26A1-4114-8A4B-97D13512A4F3Q36124146-FC8F281C-CA79-4059-90EE-0E1D572CB5C9Q38187701-18EA7675-B500-4428-BBF5-47AFD27FE17AQ38373316-02D3DE00-A937-4FAF-BCB4-058EC2C3109AQ38625133-72D2539D-CA18-44DE-9AB5-B6459729EBE7Q45948328-D05152DB-D0CA-42D7-8F72-3952195CAB3BQ47968881-3AFA1E72-1F5E-4D21-8D1C-09D0EC12EF5CQ52690736-DC358360-1378-4040-BC5F-B9D161242C0AQ54306979-5E4CCE51-6983-4CFB-8945-E02433C9E2DEQ54686050-B1206EC5-E16B-44E1-8BE4-1F1F6A52364EQ82941785-750F9D7A-D443-44EF-A3FC-B2BA9E6B65CFQ83028742-B9066925-E287-498D-812C-EF68A1154803Q84149352-12B38E65-6EF3-4E30-92D0-BF64D7A36CB3Q84862419-AE8CB426-82CF-4D53-B92E-9882B1AB63C8
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8928-7049
@en
name
Chakradhara Rao S Uppugunduri
@ast
Chakradhara Rao S Uppugunduri
@en
Chakradhara Rao S Uppugunduri
@es
Chakradhara Rao S Uppugunduri
@nl
type
label
Chakradhara Rao S Uppugunduri
@ast
Chakradhara Rao S Uppugunduri
@en
Chakradhara Rao S Uppugunduri
@es
Chakradhara Rao S Uppugunduri
@nl
prefLabel
Chakradhara Rao S Uppugunduri
@ast
Chakradhara Rao S Uppugunduri
@en
Chakradhara Rao S Uppugunduri
@es
Chakradhara Rao S Uppugunduri
@nl
P106
P1153
36680829500
P31
P496
0000-0002-8928-7049